NasdaqGS - Nasdaq Real Time Price • USD
MacroGenics, Inc. (MGNX)
At close: 4:00 PM EDT
After hours: 4:20 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 11 | 10 | 11 | 8 |
| Avg. Estimate | -0.64 | -0.56 | -2.48 | -1.8 |
| Low Estimate | -0.77 | -0.76 | -2.98 | -3.6 |
| High Estimate | -0.55 | 0.16 | -1.57 | 0.58 |
| Year Ago EPS | -0.61 | 0.92 | -0.15 | -2.48 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 11 | 10 | 11 | 7 |
| Avg. Estimate | 14.62M | 16.71M | 68.77M | 140.48M |
| Low Estimate | 10.29M | 10.38M | 42.47M | 70M |
| High Estimate | 22.7M | 37.7M | 125.7M | 326.22M |
| Year Ago Sales | 24.5M | -- | 58.75M | 68.77M |
| Sales Growth (year/est) | -40.30% | -- | 17.10% | 104.30% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 0.45 | -0.52 | -0.1 | -0.15 |
| EPS Actual | -0.61 | 0.92 | 0.28 | -0.75 |
| Difference | -1.06 | 1.44 | 0.38 | -0.6 |
| Surprise % | -235.60% | 276.90% | 380.00% | -400.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.64 | -0.56 | -2.48 | -1.8 |
| 7 Days Ago | -0.64 | -0.64 | -2.58 | -2.01 |
| 30 Days Ago | -0.62 | -0.63 | -2.55 | -1.02 |
| 60 Days Ago | -0.48 | -0.51 | -1.84 | -1.04 |
| 90 Days Ago | -0.47 | -0.49 | -1.87 | -1.25 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | 1 | 1 | 1 | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | MGNX | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -4.90% | -- | -- | 5.80% |
| Next Qtr. | -160.90% | -- | -- | 12.10% |
| Current Year | -1,553.30% | -- | -- | 4.80% |
| Next Year | 27.40% | -- | -- | 13.10% |
| Next 5 Years (per annum) | -283.60% | -- | -- | 10.96% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Upgrade | TD Cowen: Hold to Buy | 4/9/2024 |
| Reiterates | JMP Securities: Market Outperform | 4/4/2024 |
| Maintains | Citigroup: Buy to Buy | 3/11/2024 |
| Maintains | JMP Securities: Outperform to Outperform | 3/11/2024 |
| Maintains | HC Wainwright & Co.: Neutral to Neutral | 3/11/2024 |
| Maintains | BMO Capital: Outperform to Outperform | 3/8/2024 |
Related Tickers
CTMX CytomX Therapeutics, Inc.
5.13
+214.72%
XNCR Xencor, Inc.
23.93
+14.28%
MRSN Mersana Therapeutics, Inc.
3.3700
+6.31%
KPTI Karyopharm Therapeutics Inc.
1.0800
+4.85%
STOK Stoke Therapeutics, Inc.
11.56
+4.81%
ADCT ADC Therapeutics SA
4.7100
+6.80%
INSM Insmed Incorporated
25.59
+3.52%
KYMR Kymera Therapeutics, Inc.
36.24
+7.79%
IMCR Immunocore Holdings plc
59.05
-0.05%
IGMS IGM Biosciences, Inc.
9.48
-1.56%